Transition Bio

Series A

Cambridge, UKJun 2022

Transition Bio raised €47M in a Series A round in Jun 2022. The company is based in Cambridge, UK. Investors in the round: Bristol Myers Squibb, Lifeforce Capital, Magnetic Ventures and 2 others. Data as of Nov 2026.

← Transition Bio

Amount raised

€47M

€46,598,322

Native amount

50,000,000 USD

Stage

Series A

series a

Investors

Provenance & confidence

High confidence

Amount

50,000,000 USD

ECB-at-date → €47M · rate 1.073 on 2022-06-03

High confidence

Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named

Bristol Myers Squibb Lifeforce Capital Magnetic Ventures Northpond Ventures Taiho Ventures

Date

Jun 2022

Round type

series a

Amount (EUR)

€47M

Other rounds

same company

This is the company's only recorded round.

Transition Bio

Provenance & confidence

Investors in this round

Other rounds

Related news